NASDAQ · IBB
iShares Biotechnology ETF
$217.61-$0.25 (-0.11%)
iShares Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
Loading market information…
AMEX · TCAF · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
T. Rowe Capital Appreciation Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
T. Rowe Capital Appreciation Equity ETF’s forward annual dividend is $0.19 per share, paid annual. The forward yield is 0.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Capital Appreciation Equity ETF is an exchange-traded fund launched and managed by T. Rowe Price Associates, Inc. The fund is co-managed by T. Rowe Price Investment Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of large-cap companies. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. The fund employs fundamental analysis with a bottom-up stock-picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the Russell 3000 Index and the S&P 500 Index. T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Capital Appreciation Equity ETF was formed on June 14, 2023 and is domiciled in the United States.?
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$217.61-$0.25 (-0.11%)
iShares Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$101.11-$4.88 (-4.6%)
iShares MSCI Taiwan ETF’s quoted price sits in the upper half of its reported 52-week range, 14.65% below the high.
$136.12-$2.59 (-1.87%)
JPMorgan BetaBuilders U.S. Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.63% below the high.
$42.70-$0.73 (-1.68%)
Fidelity Enhanced Large Cap Core ETF’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
$53.84+$0.58 (+1.09%)
First Trust Morningstar Dividend Leaders Index Fund’s quoted price sits in the upper half of its reported 52-week range, 0.63% below the high.
$98.57-$3.12 (-3.07%)
First Trust RBA American Industrial RenaissanceTM ETF’s quoted price sits in the lower half of its reported 52-week range, 27.01% below the high.
$43.05-$0.94 (-2.14%)
iShares U.S. Thematic Rotation Active ETF’s quoted price sits in the upper half of its reported 52-week range, 4.42% below the high.
$77.57-$0.79 (-1.01%)
JPMorgan BetaBuilders International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.17% below the high.
